Publications by authors named "Marco Emili"

Claim this Profile
D
Dendritic phenotype and proliferation potency in the hippocampal dentate gyrus of the Ts66Yah model of Down syndrome.
Marco Emili, Fiorenza Stagni, Sandra Guidi, Carla Russo, Claire Chevalier

Neurosci Lett· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model.
Marco Emili, Fiorenza Stagni, Carla Russo, Laura Angelozzi, Sandra Guidi

Neuropharmacology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellularity Defects Are Not Ubiquitous in the Brains of Fetuses With Down Syndrome.
Marco Emili, Fiorenza Stagni, Maria Paola Bonasoni, Sandra Guidi, Renata Bartesaghi

Dev Neurobiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Appearance of Dendritic Alterations in Neocortical Pyramidal Neurons of the Ts65Dn Model of Down Syndrome.
Beatrice Uguagliati, Fiorenza Stagni, Marco Emili, Andrea Giacomini, Carla Russo

Dev Neurosci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders.
Marco Emili, Sandra Guidi, Beatrice Uguagliati, Andrea Giacomini, Renata Bartesaghi

Crit Rev Food Sci Nutr· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone.
Daniela Valenti, Fiorenza Stagni, Marco Emili, Sandra Guidi, Renata Bartesaghi

Antioxidants (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome.
Beatrice Uguagliati, Abdel-Rahman Al-Absi, Fiorenza Stagni, Marco Emili, Andrea Giacomini

Hippocampus· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome.
Fiorenza Stagni, Beatrice Uguagliati, Marco Emili, Andrea Giacomini, Renata Bartesaghi

Sci Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome.
Marco Emili, Fiorenza Stagni, Maria Elisa Salvalai, Beatrice Uguagliati, Andrea Giacomini

Neurobiol Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroanatomical alterations in higher-order thalamic nuclei of fetuses with Down syndrome.
Fiorenza Stagni, Andrea Giacomini, Marco Emili, Beatrice Uguagliati, Maria Paola Bonasoni

Clin Neurol Neurosurg· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome.
Fiorenza Stagni, Maria Elisa Salvalai, Andrea Giacomini, Marco Emili, Beatrice Uguagliati

Neurobiol Dis· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse.
Andrea Giacomini, Fiorenza Stagni, Marco Emili, Beatrice Uguagliati, Roberto Rimondini

Antioxidants (Basel)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome.
Fiorenza Stagni, Andrea Giacomini, Marco Emili, Beatrice Uguagliati, Maria Paola Bonasoni

Brain Pathol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal development of the inferior temporal region in fetuses with Down syndrome.
Sandra Guidi, Andrea Giacomini, Fiorenza Stagni, Marco Emili, Beatrice Uguagliati

Brain Pathol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lithium Restores Age-related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome.
Sandra Guidi, Patrizia Bianchi, Fiorenza Stagni, Andrea Giacomini, Marco Emili

CNS Neurol Disord Drug Targets· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
Andrea Giacomini, Fiorenza Stagni, Marco Emili, Sandra Guidi, Maria Elisa Salvalai

Brain Res Bull· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurogenesis impairment: An early developmental defect in Down syndrome.
Fiorenza Stagni, Andrea Giacomini, Marco Emili, Sandra Guidi, Renata Bartesaghi

Free Radic Biol Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
Fiorenza Stagni, Andrea Giacomini, Sandra Guidi, Marco Emili, Beatrice Uguagliati

Exp Neurol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
Vincenzo Roncacé, Costanza Burattini, Fiorenza Stagni, Sandra Guidi, Andrea Giacomini, Marco Emili

Neurobiol Dis· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome.
Fiorenza Stagni, Alessandra Raspanti, Andrea Giacomini, Sandra Guidi, Marco Emili

Neurobiol Dis· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome?
Fiorenza Stagni, Andrea Giacomini, Marco Emili, Sandra Guidi, Elisabetta Ciani

Neurogenesis (Austin)· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
Fiorenza Stagni, Andrea Giacomini, Marco Emili, Stefania Trazzi, Sandra Guidi

Neuroscience· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome.
Andrea Giacomini, Fiorenza Stagni, Stefania Trazzi, Sandra Guidi, Marco Emili

Neurobiol Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis